Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lenzhofer

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|January 1, 1980
Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromasG Baumgartner, R Heinz, H Arbes, et al.
Wiener Klinische Wochenschrift|February 20, 1981
[Case report of a patient with intermittent fever, leucopenia and terminal fungal sepsis (author's transl)]R Lenzhofer, H Pointner, K H Tragl, et al.
Experientia|January 15, 1983
Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substancesR Lenzhofer, D Magometschnigg, R Dudczak, et al.
Wiener Klinische Wochenschrift|April 15, 1983
Plasmapheresis in the treatment of myasthenia gravisR Lenzhofer, W Graninger, C Dittrich, et al.
The Clinical Investigator|July 1, 1993
Acute jejunal ileus in intestinal lymphangiectasiaR Lenzhofer, M Lindner, A Moser, et al.
Leber, Magen, Darm|February 1, 1982
[Diagnosis of colitis in Behçet's syndrome (author's transl)]S Meryn, P Ferenci, H Pamperl, et al.
Wiener Klinische Wochenschrift|November 25, 1983
[Significance of laboratory chemical parameters for the detection of metastases in breast cancer]K Pirich, W Graninger, B Schneeweiss, et al.
Cancer Detection and Prevention|January 1, 1985
Carcinoembryonic antigen (CEA) plasma level determination in the management of gastric cancer patientsC Dittrich, R Jakesz, L Havelec, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathyR Lenzhofer, R Dudczak, G Gumhold, et al.
Deutsche Medizinische Wochenschrift (1946)|May 20, 1983
[Monitoring of cardiac function during doxorubicin therapy in metastasized breast cancer. Measuring systolic time interval]R Lenzhofer, R Dudczak, C Dittrich, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|January 1, 1980
Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromasG Baumgartner, R Heinz, H Arbes, et al.
Wiener Klinische Wochenschrift|February 20, 1981
[Case report of a patient with intermittent fever, leucopenia and terminal fungal sepsis (author's transl)]R Lenzhofer, H Pointner, K H Tragl, et al.
Experientia|January 15, 1983
Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substancesR Lenzhofer, D Magometschnigg, R Dudczak, et al.
Wiener Klinische Wochenschrift|April 15, 1983
Plasmapheresis in the treatment of myasthenia gravisR Lenzhofer, W Graninger, C Dittrich, et al.
The Clinical Investigator|July 1, 1993
Acute jejunal ileus in intestinal lymphangiectasiaR Lenzhofer, M Lindner, A Moser, et al.
Leber, Magen, Darm|February 1, 1982
[Diagnosis of colitis in Behçet's syndrome (author's transl)]S Meryn, P Ferenci, H Pamperl, et al.
Wiener Klinische Wochenschrift|November 25, 1983
[Significance of laboratory chemical parameters for the detection of metastases in breast cancer]K Pirich, W Graninger, B Schneeweiss, et al.
Cancer Detection and Prevention|January 1, 1985
Carcinoembryonic antigen (CEA) plasma level determination in the management of gastric cancer patientsC Dittrich, R Jakesz, L Havelec, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathyR Lenzhofer, R Dudczak, G Gumhold, et al.
Deutsche Medizinische Wochenschrift (1946)|May 20, 1983
[Monitoring of cardiac function during doxorubicin therapy in metastasized breast cancer. Measuring systolic time interval]R Lenzhofer, R Dudczak, C Dittrich, et al.
Pageof 5